Literature DB >> 1541557

Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

E Blasi1, L Pitzurra, M Puliti, L Lanfrancone, F Bistoni.   

Abstract

The dimorphic transition of Candida albicans from the yeast (Y-Candida) to the hyphal (H-Candida) form is a complex event; the relevance of this transition in fungal pathogenicity is still poorly understood. By using a cloned macrophage cell line (ANA-1), we questioned whether the interaction between macrophages and Y-Candida or H-Candida could affect specific cell functions, i.e., tumor necrosis factor and lysozyme production. We found that ANA-1 macrophages selectively responded to H-Candida with increased tumor necrosis factor and downregulated lysozyme, as assessed by measurement of relative mRNA levels and secreted biological activities. The H-Candida-mediated effects were (i) dependent upon the ratio between ANA-1 macrophages and H-Candida, (ii) detectable after 1 h of coincubation, and (iii) accomplished without fungal ingestion. Conversely, Y-Candida, which was found inside the ANA-1 macrophages, did not affect tumor necrosis factor and lysozyme production, nor did it prevent the macrophage response to other stimuli. Overall, these results indicate that a macrophage can distinguish between Y-Candida and H-Candida and that only the latter is able to modulate specific functions. H-Candida is recognized and probably processed as an extracellular target. The possible implication of macrophages as autocrine and paracrine regulatory cells during Candida infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541557      PMCID: PMC257562          DOI: 10.1128/iai.60.3.832-837.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Intracerebral transfer of an in vitro established microglial cell line: local induction of a protective state against lethal challenge with Candida albicans.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; A Bartoli; F Bistoni
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

2.  Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus.

Authors:  E Blasi; R Barluzzi; V Bocchini; R Mazzolla; F Bistoni
Journal:  J Neuroimmunol       Date:  1990-05       Impact factor: 3.478

3.  Variability in expression of cell surface antigens of Candida albicans during morphogenesis.

Authors:  D L Brawner; J E Cutler
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

4.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall.

Authors:  A Vecchiarelli; M Puliti; A Torosantucci; A Cassone; F Bistoni
Journal:  Cell Immunol       Date:  1991-04-15       Impact factor: 4.868

6.  Opportunistic infections and immune deficiency in homosexual men.

Authors:  D Mildvan; U Mathur; R W Enlow; P L Romain; R J Winchester; C Colp; H Singman; B R Adelsberg; I Spigland
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Purification and characterization of a human tumor necrosis factor from the LuKII cell line.

Authors:  B Y Rubin; S L Anderson; S A Sullivan; B D Williamson; E A Carswell; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils.

Authors:  T Arai; Y Mikami; K Yokoyama
Journal:  Sabouraudia       Date:  1977-07

9.  A rapid Candida albicans hyphal-form growth inhibition assay: determination of myelomonocytic-mediated antifungal activity.

Authors:  L Scaringi; E Blasi; P Cornacchione; C Bietta; F Bistoni
Journal:  Mycoses       Date:  1991 Mar-Apr       Impact factor: 4.377

10.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

2.  Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis.

Authors:  Evelyn E Nash; Brian M Peters; Glen E Palmer; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

3.  Influence of the Bcg locus on macrophage response to the dimorphic fungus Candida albicans.

Authors:  M Puliti; D Radzioch; R Mazzolla; R Barluzzi; F Bistoni; E Blasi
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

4.  Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes.

Authors:  G Raponi; M C Ghezzi; C Mancini; F Filadoro
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Differential susceptibility of yeast and hyphal forms of Candida albicans to proteolytic activity of macrophages.

Authors:  E Blasi; L Pitzurra; A R Chimienti; R Mazzolla; M Puliti; R Barluzzi; F Bistoni
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

6.  Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production.

Authors:  T Jouault; G Lepage; A Bernigaud; P A Trinel; C Fradin; J M Wieruszeski; G Strecker; D Poulain
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds.

Authors:  E Blasi; L Pitzurra; M Puliti; A R Chimienti; R Mazzolla; R Barluzzi; F Bistoni
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages.

Authors:  T Jouault; A Bernigaud; G Lepage; P A Trinel; D Poulain
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 9.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

10.  Tumor necrosis factor as an autocrine and paracrine signal controlling the macrophage secretory response to Candida albicans.

Authors:  E Blasi; L Pitzurra; A Bartoli; M Puliti; F Bistoni
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.